Harvard Diabetes and Obesity Implications and Complications 2025

Harvard Diabetes and Obesity Implications and Complications 2025

69 videos + 39 pdfs, size: 116 GB

Diabetes management has been transformed by GLP-1 receptor agonists, SGLT2 inhibitors, and continuous glucose monitoring. This course equips you to use these advances confidently in practice.

Harvard Medical School is consistently ranked among the world’s top medical institutions. This course is produced under the same rigorous academic standards that define Harvard’s global reputation.

💎 What You’ll Master

• Screening for diabetes and diagnostic criteria for obesity and diabetes
• Clinical approaches to weight management , including lifestyle interventions, pharmacotherapy, and surgery
• Pharmacological management of diabetes , including the latest in insulin and non-insulin therapies and their impact on weight management
• Advances in insulin delivery and glucose monitoring technologies
• Obesity as a comorbidity and its impact on diabetes progression, cardiovascular health, morbidity, and mortality
• Care considerations for older adults with diabetes and/or obesity
• Incorporating recent therapeutic advances into your practice
• Challenging patient cases and real-world applications

📚 Learning Format

Every module is designed for busy clinicians — structured for efficient learning, immediately applicable to practice, and built around evidence you can trust.

• High-definition video lectures from world-class faculty
• Downloadable slides and PDFs for offline reference
• Self-paced learning — no deadlines, no expiry
• Instant digital delivery — access within minutes of purchase

✅ What’s Included

• Complete package: 69 videos + 39 pdfs, size: 116 GB
• Instant digital delivery — access immediately after purchase
• Lifetime access — no expiry, no subscription
• Downloadable materials — study on any device, offline
• No monthly fees — one payment, permanent access

🚀 Who This Course Is For

This course is designed for endocrinologists, diabetologists, primary care physicians, cardiologists, and nephrologists managing patients with diabetes, obesity, and metabolic syndrome.